Neuropeptide AF induces anxiety-like and antidepressant-like behavior in mice

Behavioural Brain Research

Volumn 274, Issue , 2014, Pages 264-269

  Palotai, Miklós ^a   Telegdy, Gyula ^a,b   Tanaka, Masaru ^b   Bagosi, Zsolt ^a   Jászberényi, Miklós ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Elevated plus maze test; Forced swimming test; Neuropeptide AF; Neurotransmitter

Indexed keywords

ANTIDEPRESSANT AGENT; ATROPINE; CYPROHEPTADINE; HALOPERIDOL; METHYSERGIDE; NEUROPEPTIDE AF; PRAZOSIN; PROPRANOLOL; UNCLASSIFIED DRUG; A18FAMIDE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; OLIGOPEPTIDE; PHENOXYBENZAMINE; SEROTONIN RECEPTOR AFFECTING AGENT; NEUROPEPTIDE; SEROTONIN 2 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; CHOLINERGIC TRANSMISSION; CLIMBING; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ELEVATED PLUS MAZE TEST; FORCED SWIM TEST; IMMOBILIZATION; MALE; MOUSE; MUSCARINIC NEUROTRANSMISSION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; MAZE TEST; PSYCHOLOGY; SWIMMING; TONIC IMMOBILITY; PROTEIN FUNCTION; SPECIES DIFFERENCE;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; IMMOBILITY RESPONSE, TONIC; MALE; MAZE LEARNING; MICE; OLIGOPEPTIDES; PHENOXYBENZAMINE; PRAZOSIN; SEROTONIN AGENTS; SWIMMING;

EID: 84906772825     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.08.007     Document Type: Article

References (31)

1. Yang H.Y., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci U S A 1985, 82:7757-7761.
2. Bonnard E., Burlet-Schiltz O., Frances B., Mazarguil H., Monsarrat B., Zajac J.M., et al. Identification of neuropeptide FF-related peptides in rodent spinal cord. Peptides 2001, 22:1085-1092.
3. Fukusumi S., Fujii R., Hinuma S. Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 2006, 27:1073-1086.
4. Kivipelto L., Majane E.A., Yang H.Y., Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamidelike peptides in the central nervous system of rats. J Comp Neurol 1989, 286:269-287.
5. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 2000, 275:39324-39331.
6. Kavaliers M. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci Lett 1990, 115:307-312.
7. Fehmann H.C., McGregor G., Weber V., Eissele R., Goke R., Goke B., et al. The effects of two FMRFamide related peptides (A-18-F-amide and F-8-F-amide; 'morphine modulating peptides') on the endocrine and exocrine rat pancreas. Neuropeptides 1990, 17:87-92.
8. Newmyer B.A., Siegel P.B., Cline M.A. Neuropeptide AF differentially affects anorexia in lines of chickens selected for high or low body weight. J Neuroendocrinol 2010, 22:593-598.
9. 2), inhibit colonic bead expulsion time in mice. Peptides 1989, 10:873-875.
10. Desprat C., Zajac J.M. Hypothermic effects of neuropeptide FF analogues in mice. Pharmacol Biochem Behav 1997, 58:559-563.
11. 2 antiserum. Neuropeptides 1987, 10:37-42.
12. Labrouche S., Laulin J.P., Le Moal M., Tramu G., Simonnet G. Neuropeptide FF in the rat adrenal gland: presence, distribution and pharmacological effects. J Neuroendocrinol 1998, 10:559-565.
13. Jaszberenyi M., Bagosi Z., Thurzo B., Foldesi I., Szabo G., Telegdy G. Endocrine, behavioral and autonomic effects of neuropeptide AF. Horm Behav 2009, 56:24-34.
14. van Harmelen V., Dicker A., Sjolin E., Blomqvist L., Wiren M., Hoffstedt J., et al. Effects of pain controlling neuropeptides on human fat cell lipolysis. Int J Obes 2010, 34:1333-1340.
15. Newmyer B.A., Cline M.A. Neuropeptide SF is associated with reduced food intake in chicks. Behav Brain Res 2009, 205:311-314.
16. Yudin Y.K., Tamarova Z.A., Krishtal O.A. Peripherally applied neuropeptide SF is equally algogenic in wild type and ASIC3-/- mice. Neurosci Res 2006, 55:421-425.
17. Jaszberenyi M., Bagosi Z., Csabafi K., Palotai M., Telegdy G. The actions of neuropeptide SF on the hypothalamic-pituitary-adrenal axis and behavior in rats. Regul Pept 2014, 188:46-51.
18. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
19. Khisti R.T., Chopde C.T., Jain S.P. Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 2000, 67:137-143.
20. Tanaka M., Telegdy G. Neurotransmissions of antidepressant-like effects of neuromedin U-23 in mice. Behav Brain Res 2014, 259:196-199.
21. Tanaka M., Schally A.V., Telegdy G. Neurotransmission of the antidepressant-like effects of the growth hormone-releasing hormone antagonist MZ-4-71. Behav Brain Res 2012, 228:388-391.
22. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
23. Lang U.E., Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem: Int J Exp Cell Physiol Biochem Pharmacol 2013, 31:761-777.
24. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
25. Soga T., Wong D.W., Clarke I.J., Parhar I.S. Citalopram (antidepressant) administration causes sexual dysfunction in male mice through RF-amide related peptide in the dorsomedial hypothalamus. Neuropharmacology 2010, 59:77-85.
26. Tanaka M., Csabafi K., Telegdy G. Neurotransmissions of antidepressant-like effects of kisspeptin-13. Regul Pept 2013, 180:1-4.
27. Ogren S.O., Kuteeva E., Elvander-Tottie E., Hokfelt T. Neuropeptides in learning and memory processes with focus on galanin. Eur J Pharmacol 2010, 626:9-17.
28. Agorastos A., Demiralay C., Huber C.G. Influence of religious aspects and personal beliefs on psychological behavior: focus on anxiety disorders. Psychol Res Behav Manage 2014, 7:93-101.
29. Csabafi K., Jaszberenyi M., Bagosi Z., Liptak N., Telegdy G. Effects of kisspeptin-13 on the hypothalamic-pituitary-adrenal axis, thermoregulation, anxiety and locomotor activity in rats. Behav Brain Res 2013, 241:56-61.
30. Kotlinska J.H., Gibula-Bruzda E., Koltunowska D., Raoof H., Suder P., Silberring J. Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats. Peptides 2012, 33:156-163.
31. Kotlinska J., Pachuta A., Bochenski M., Silberring J. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats. Peptides 2009, 30:1165-1172.